Your browser doesn't support javascript.
loading
Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases.
Arias, Armando; Watson, Simon J; Asogun, Danny; Tobin, Ekaete Alice; Lu, Jia; Phan, My V T; Jah, Umaru; Wadoum, Raoul Emeric Guetiya; Meredith, Luke; Thorne, Lucy; Caddy, Sarah; Tarawalie, Alimamy; Langat, Pinky; Dudas, Gytis; Faria, Nuno R; Dellicour, Simon; Kamara, Abdul; Kargbo, Brima; Kamara, Brima Osaio; Gevao, Sahr; Cooper, Daniel; Newport, Matthew; Horby, Peter; Dunning, Jake; Sahr, Foday; Brooks, Tim; Simpson, Andrew J H; Groppelli, Elisabetta; Liu, Guoying; Mulakken, Nisha; Rhodes, Kate; Akpablie, James; Yoti, Zabulon; Lamunu, Margaret; Vitto, Esther; Otim, Patrick; Owilli, Collins; Boateng, Isaac; Okoror, Lawrence; Omomoh, Emmanuel; Oyakhilome, Jennifer; Omiunu, Racheal; Yemisis, Ighodalo; Adomeh, Donatus; Ehikhiametalor, Solomon; Akhilomen, Patience; Aire, Chris; Kurth, Andreas; Cook, Nicola; Baumann, Jan.
Afiliación
  • Arias A; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Watson SJ; Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
  • Asogun D; Irrua Specialist Teaching Hospital, Institute of Lassa Fever Research and Control, Irrua, Nigeria.
  • Tobin EA; The European Mobile Laboratory Consortium, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Lu J; Irrua Specialist Teaching Hospital, Institute of Lassa Fever Research and Control, Irrua, Nigeria.
  • Phan MVT; The European Mobile Laboratory Consortium, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Jah U; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Wadoum REG; Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
  • Meredith L; University of Makeni, Makeni, Sierra Leone.
  • Thorne L; University of Makeni, Makeni, Sierra Leone.
  • Caddy S; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Tarawalie A; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Langat P; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Dudas G; University of Makeni, Makeni, Sierra Leone.
  • Faria NR; Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
  • Dellicour S; Institute of Evolutionary Biology, Ashworth Laboratories, Edinburgh, United Kingdom.
  • Kamara A; Department of Zoology, University of Oxford, Oxford, UK.
  • Kargbo B; Department of Zoology, University of Oxford, Oxford, UK.
  • Kamara BO; Sierra Leone Ministry of Health, Freetown, Sierra Leone.
  • Gevao S; Sierra Leone Ministry of Health, Freetown, Sierra Leone.
  • Cooper D; Sierra Leone Ministry of Health, Freetown, Sierra Leone.
  • Newport M; Sierra Leone Ministry of Health, Freetown, Sierra Leone.
  • Horby P; International Medical Corps, Los Angeles, CA, USA.
  • Dunning J; International Medical Corps, Los Angeles, CA, USA.
  • Sahr F; Department of Medicine, Epidemic Diseases Research Group Oxford (ERGO), Centre for Tropical Medicine and Global Health Nuffield, University of Oxford, Oxford, United Kingdom.
  • Brooks T; Department of Medicine, Epidemic Diseases Research Group Oxford (ERGO), Centre for Tropical Medicine and Global Health Nuffield, University of Oxford, Oxford, United Kingdom.
  • Simpson AJH; Republic of Sierra Leone Armed Forces, Freetown, Sierra Leone.
  • Groppelli E; Rare and Imported Pathogens Laboratory, Public Health England, United Kingdom.
  • Liu G; Rare and Imported Pathogens Laboratory, Public Health England, United Kingdom.
  • Mulakken N; Rare and Imported Pathogens Laboratory, Public Health England, United Kingdom.
  • Rhodes K; Thermo Fisher Scientific, South San Francisco, CA, USA.
  • Akpablie J; Thermo Fisher Scientific, South San Francisco, CA, USA.
  • Yoti Z; Thermo Fisher Scientific, South San Francisco, CA, USA.
  • Lamunu M; WHO Ebola Response Team, Geneva, Switzerland.
  • Vitto E; WHO Ebola Response Team, Geneva, Switzerland.
  • Otim P; WHO Ebola Response Team, Geneva, Switzerland.
  • Owilli C; WHO Ebola Response Team, Geneva, Switzerland.
  • Boateng I; WHO Ebola Response Team, Geneva, Switzerland.
  • Okoror L; WHO Ebola Response Team, Geneva, Switzerland.
  • Omomoh E; WHO Ebola Response Team, Geneva, Switzerland.
  • Oyakhilome J; Federal University, Oye-Ekit, Nigeria.
  • Omiunu R; Irrua Specialist Teaching Hospital, Institute of Lassa Fever Research and Control, Irrua, Nigeria.
  • Yemisis I; The European Mobile Laboratory Consortium, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Adomeh D; Irrua Specialist Teaching Hospital, Institute of Lassa Fever Research and Control, Irrua, Nigeria.
  • Ehikhiametalor S; The European Mobile Laboratory Consortium, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Akhilomen P; Irrua Specialist Teaching Hospital, Institute of Lassa Fever Research and Control, Irrua, Nigeria.
  • Aire C; The European Mobile Laboratory Consortium, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Kurth A; Irrua Specialist Teaching Hospital, Institute of Lassa Fever Research and Control, Irrua, Nigeria.
  • Cook N; The European Mobile Laboratory Consortium, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Baumann J; Irrua Specialist Teaching Hospital, Institute of Lassa Fever Research and Control, Irrua, Nigeria.
Virus Evol ; 2(1): vew016, 2016 Jan.
Article en En | MEDLINE | ID: mdl-28694998
To end the largest known outbreak of Ebola virus disease (EVD) in West Africa and to prevent new transmissions, rapid epidemiological tracing of cases and contacts was required. The ability to quickly identify unknown sources and chains of transmission is key to ending the EVD epidemic and of even greater importance in the context of recent reports of Ebola virus (EBOV) persistence in survivors. Phylogenetic analysis of complete EBOV genomes can provide important information on the source of any new infection. A local deep sequencing facility was established at the Mateneh Ebola Treatment Centre in central Sierra Leone. The facility included all wetlab and computational resources to rapidly process EBOV diagnostic samples into full genome sequences. We produced 554 EBOV genomes from EVD cases across Sierra Leone. These genomes provided a detailed description of EBOV evolution and facilitated phylogenetic tracking of new EVD cases. Importantly, we show that linked genomic and epidemiological data can not only support contact tracing but also identify unconventional transmission chains involving body fluids, including semen. Rapid EBOV genome sequencing, when linked to epidemiological information and a comprehensive database of virus sequences across the outbreak, provided a powerful tool for public health epidemic control efforts.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Virus Evol Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Virus Evol Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido